Current and emerging therapies for Alzheimer's disease.

Abstract:

:Alzheimer's disease (AD) is a devastating neurodegenerative disorder, with a rapidly increasing worldwide prevalence. Although no cure for AD has yet been found, substantial progress has been made in our understanding of AD pathogenesis. This progress has led to the development of numerous promising compounds in various stages of clinical testing. In this review, the current pharmacologic treatments for AD are discussed in detail, followed by an overview of the main experimental strategies that will shape AD therapeutics over the next decade.

journal_name

Clin Ther

journal_title

Clinical therapeutics

authors

Nygaard HB

doi

10.1016/j.clinthera.2013.09.009

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

1480-9

issue

10

eissn

0149-2918

issn

1879-114X

pii

S0149-2918(13)00960-0

journal_volume

35

pub_type

杂志文章,评审
  • Sex-specific Outcomes in a Substance Use Intervention Program.

    abstract:PURPOSE:We performed an emergency department (ED)-based substance use screening, motivational interview-based intervention, and treatment referral program with the goal of determining sex-specific outcomes. Specifically, in this quality improvement project, we aimed to determine whether there was a difference among sex...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2020.01.020

    authors: Amaducci AM,Greenberg MR,Sheen AW,Warren HR,Parikh PM,Roth P,Weaver KR,Richardson DM,Burmeister DB,Stephens JL,Cannon RD

    更新日期:2020-03-01 00:00:00

  • Tolerability and pharmacokinetics of two formulations of megestrol acetate under fed conditions in healthy volunteers.

    abstract:PURPOSE:Megestrol acetate oral suspension is an appetite stimulant indicated for cachexia. It is available in a conventional formulation and as a nanocrystal dispersion. The aim of this study was to compare the tolerability and pharmacokinetics of these formulations under fed conditions in healthy Korean volunteers. M...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.clinthera.2014.09.022

    authors: Kim YH,Choi HY,Jin S,Noh YH,Kim MJ,Park HJ,Lim HS,Bang K,Lee SH,Bae KS

    更新日期:2015-02-01 00:00:00

  • Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.

    abstract:BACKGROUND:Many patients and physicians interpret episodic headache in the presence or absence of nasal symptoms as "sinus' headache, while ignoring the possible diagnosis of migraine. OBJECTIVE:The purpose of this study was to assess the efficacy and tolerability of sumatriptan succinate 50-mg tablets in patients wit...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.clinthera.2007.01.012

    authors: Ishkanian G,Blumenthal H,Webster CJ,Richardson MS,Ames M

    更新日期:2007-01-01 00:00:00

  • Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

    abstract:BACKGROUND:Therapeutic drug monitoring (TDM) is essential to maintain the efficacy of many immunosuppressant drugs while minimizing their toxicity. TDM has become more refined with the development of new monitoring techniques and more specific assays. OBJECTIVE:This article summarizes current data on TDM of the follow...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0149-2918(02)85038-x

    authors: Kahan BD,Keown P,Levy GA,Johnston A

    更新日期:2002-03-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.

    abstract::The pharmacodynamic parameter that appears to correlate best with a successful therapeutic outcome with beta-lactam antibiotics is the length of time the serum antibiotic concentration remains above the minimum inhibitory concentration (MIC) for the infecting pathogen. By maximizing this parameter, continuous administ...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/S0149-2918(00)86736-3

    authors: Burgess DS,Summers KK,Hardin TC

    更新日期:1999-11-01 00:00:00

  • Valuation of medical resource units collected in health economic studies.

    abstract::This paper reviews the issues that are critical for the valuation of medical resources in the context of health economic studies. There are several points to consider when undertaking the valuation of medical resources. The perspective of the analysis should be established before determining the valuation process. Fut...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:

    authors: Copley-Merriman C,Lair TJ

    更新日期:1994-05-01 00:00:00

  • Propofol Use in the Elderly Population: Prevalence of Overdose and Association With 30-Day Mortality.

    abstract:PURPOSE:Geriatric patients are more sensitive to the anesthetic effects of propofol and its adverse effects, such as hypotension, than is the general population; thus, a reduced dose (1-1.5 mg/kg) is recommended for the induction of anesthesia. The extent to which clinicians follow established dosing guidelines has not...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2015.10.005

    authors: Phillips AT,Deiner S,Mo Lin H,Andreopoulos E,Silverstein J,Levin MA

    更新日期:2015-12-01 00:00:00

  • Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.

    abstract:BACKGROUND:Migraine is a common, chronic, often disabling neurologic condition that is underdiagnosed and undertreated. OBJECTIVE:We undertook this questionnaire-based study as a substudy of a multicenter trial of rizatriptan effectiveness. Our goal was to assess the history of acute migraine medication use and the re...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/s0149-2918(03)80204-7

    authors: Ceballos Hernansanz MA,Sanchez Roy R,Cano Orgaz A,López-Gil A,START 10 Study Group.

    更新日期:2003-07-01 00:00:00

  • Integrins: Integrating the Biology and Therapy of Cell-cell Interactions.

    abstract:PURPOSE:Although the role of integrins has been described in a variety of diseases, these roles seem to be distinct. To date, no study has attempted to provide links to the various pathways by which such integrins can be involved in these diverse disease settings. The purpose of this review was to address this gap in o...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.clinthera.2017.11.002

    authors: Pandolfi F,Franza L,Altamura S,Mandolini C,Cianci R,Ansari A,Kurnick JT

    更新日期:2017-12-01 00:00:00

  • Effects of benzothiazepine derivative (CRD-401) on blood pressure, excretion of electrolytes, and plasma renin activity.

    abstract::A benzothiazepine derivative, CRD-401, was administered orally in a dosage of 60 to 120 mg/day to 14 patients with various renal diseases. The systolic pressure was lowered slightly in some cases after administration of CRD-401. Urine volume and urinary excretion of electrolytes were increased by the drug in most pati...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:

    authors: Funyu T,Nigawara K,Ohno K,Hamada W,Yagihashi Y

    更新日期:1981-01-01 00:00:00

  • Treating hypertension to reduce cardiovascular risk: a Korean perspective.

    abstract:BACKGROUND:Hypertension usually clusters with other cardiovascular risk factors; however, it has not been reported whether hypertension treatment has an impact on the awareness and treatment of other cardiovascular risk factors such as diabetes mellitus and hypercholesterolemia. OBJECTIVE:To analyze the effect of hype...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2012.05.006

    authors: Kim KI,Kim CH

    更新日期:2012-07-01 00:00:00

  • Review of the therapeutic uses of liraglutide.

    abstract:BACKGROUND:Glucagon-like peptide (GLP-1) is a neuroendocrine hormone that increases blood glucose and is a drug target for treatment of type 2 diabetes. Liraglutide, a subcutaneous, once-daily GLP-1 agonist, is approved for the treatment of type 2 diabetes in the United States and Europe. It also has been studied for w...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.clinthera.2011.06.004

    authors: Ryan GJ,Foster KT,Jobe LJ

    更新日期:2011-07-01 00:00:00

  • Importance of observational studies in clinical practice.

    abstract:BACKGROUND:In this era of evidence-based medicine, clinicians require a comprehensive range of well-designed studies to support prescribing decisions and patient management. In recent years, data from observational studies have become an increasingly important source of evidence because of improvements in observational...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.clinthera.2007.07.004

    authors: Ligthelm RJ,Borzì V,Gumprecht J,Kawamori R,Wenying Y,Valensi P

    更新日期:2007-06-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.

    abstract:BACKGROUND:Impaired mineral homeostasis affecting calcium, phosphate, and magnesium is a result of parathyroid hormone (PTH) deficiency in hypoparathyroidism. The current standard of treatment with active vitamin D and oral calcium does not control levels of these major minerals. Recombinant full-length human PTH 1-84 ...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2014.04.001

    authors: Clarke BL,Kay Berg J,Fox J,Cyran JA,Lagast H

    更新日期:2014-05-01 00:00:00

  • Steady-state dose proportionality of a once-a-day sustained-release diltiazem hydrochloride formulation in healthy subjects.

    abstract::In this open-label, randomized, cross-over study, 12 healthy subjects received four doses of a new sustained-release formulation of diltiazem hydrochloride for six consecutive days. Blood samples were drawn on days 5 and 6 for determination of plasma diltiazem and desacetyldiltiazem levels. The peak concentrations aft...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Ziemniak J,Colligon I,Heald D

    更新日期:1992-03-01 00:00:00

  • Effects of three beta-blocker eye drops on the rabbit cornea: an electron microscope study.

    abstract::The effects on corneal tissue of three marketed beta-blocker eye drops, carteolol 1% and 2%, befunolol 0.5% and 1%, and timolol 0.25% and 0.5%, were studied by instilling these drops into the eyes of rabbits twice daily for two consecutive months. The corneal sections were examined under a scanning electron microscope...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:

    authors: Segawa K,Nagai T,Tanaka N,Nishiyama K

    更新日期:1986-01-01 00:00:00

  • Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.

    abstract:OBJECTIVE:This study was undertaken to examine the dose-response relationship of zafirlukast (5 to 40 mg BID) and to assess the efficacy and tolerability of the 10-mg BID dose in school-aged children with mild to moderate asthma. BACKGROUND:The efficacy and tolerability of zafirlukast, an oral leukotriene-receptor ant...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/S0149-2918(00)90007-9

    authors: Pearlman DS,Lampl KL,Dowling PJ Jr,Miller CJ,Bonuccelli CM

    更新日期:2000-06-01 00:00:00

  • The treatment of sepsis and other complications in the trauma patient.

    abstract::Immediate complications of trauma and shock include right heart failure, acute respiratory distress syndrome, coagulopathy, brain edema, small bowel dysfunction, renal failure, and immune dysfunction. Nosocomial infections are also common in trauma patients. These infections are the combined result of a compromised ho...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,评审

    doi:

    authors: Trunkey DD

    更新日期:1990-01-01 00:00:00

  • Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propiona

    abstract:BACKGROUND:The use of dry-powder inhalers (DPIs) to administer respiratory medicines is increasing, and new DPIs are likely to be developed because of expiring patents. However, there is considerable debate concerning the extent to which DPIs are interchangeable without altering disease control or the safety profile of...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2009.02.007

    authors: Daley-Yates PT,Parkins DA,Thomas MJ,Gillett B,House KW,Ortega HG

    更新日期:2009-02-01 00:00:00

  • Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis.

    abstract:BACKGROUND:Few effective treatment methods are available for subacute sclerosing panencephalitis (SSPE),an infection associated with the measles virus. Interferons have shown some benefit in previous studies and clinical practice. OBJECTIVE:The purpose of this study was to compare the efficacy of 2 different regimens ...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2004.11.002

    authors: Anlar B,Aydin OF,Guven A,Sonmez FM,Kose G,Herguner O

    更新日期:2004-11-01 00:00:00

  • Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

    abstract:BACKGROUND:The emergence of multidrug-resistant nosocomial pathogens, such as Pseudomonas aeruginosa and Acinetobacter baumannii, has led to the revival of the systemic use of antimicrobial agent colistin in critically ill patients, but only limited data are available to define its pharmacokinetic profile in these pati...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.clinthera.2008.01.015

    authors: Markou N,Markantonis SL,Dimitrakis E,Panidis D,Boutzouka E,Karatzas S,Rafailidis P,Apostolakos H,Baltopoulos G

    更新日期:2008-01-01 00:00:00

  • Changes in the number of beta-adrenergic receptors of lymphocytes in patients with varying degrees of congestive heart failure.

    abstract::This study was designed to determine changes in the number of beta-adrenergic receptors of circulating lymphocytes in patients with varying degrees of congestive heart failure. Thirty-seven patients with congestive heart failure were classified into four groups according to the functional classifications of the New Yo...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:

    authors: Okada N,Ito T,Satake T

    更新日期:1989-05-01 00:00:00

  • A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.

    abstract::The management of patients with congestive heart failure (CHF) can place a significant economic burden on managed care organizations, leading providers to seek treatments that are cost-effective. Diuretics play a significant role in the treatment of edema associated with CHF. We evaluated the use of 2 loop diuretics, ...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0149-2918(99)80007-1

    authors: Noe LL,Vreeland MG,Pezzella SM,Trotter JP

    更新日期:1999-05-01 00:00:00

  • Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.

    abstract:BACKGROUND:Alzheimer's disease (AD) is estimated to affect up to 11% of those aged > or =65 years in the United States, and the number of patients with AD is predicted to increase over the next few decades as the population ages. The substantial social and economic burden associated with AD is well established, with th...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0149-2918(03)80171-6

    authors: Migliaccio-Walle K,Getsios D,Caro JJ,Ishak KJ,O'Brien JA,Papadopoulos G,AHEAD Study Group.

    更新日期:2003-06-01 00:00:00

  • Treatment of chancroid with spectinomycin or co-trimoxazole.

    abstract::Chancroid, the third most prevalent venereal disease in Thailand, was treated with a single 2-gm dose of spectinomycin, or two tablets of co-trimoxazole (trimethoprim-sulfamethoxazole) twice daily for seven days. The differences in cure rates between the two groups were statistically significant. The chancroidal ulcer...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Traisupa A,Ariyarit C,Metheeprapha C,Buatiang A,Sungthong P

    更新日期:1990-05-01 00:00:00

  • A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.

    abstract:PURPOSE:The goal of this study was to assess and compare the potential clinical and economic value of emerging bone-forming agents using the only currently available agent, teriparatide, as a reference case in patients at high, near-term (imminent, 1- to 2-year) risk of osteoporotic fractures, extending to a lifetime h...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.clinthera.2017.05.348

    authors: O'Hanlon CE,Parthan A,Kruse M,Cartier S,Stollenwerk B,Jiang Y,Caloyeras JP,Crittenden DB,Barron R

    更新日期:2017-07-01 00:00:00

  • Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

    abstract:BACKGROUND:Venous thromboembolism (VTE) prophylaxis in medically ill patients has received a level 1A recommendation in previously published clinical guidelines. Pharmacologic prophylaxis for VTE includes unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), and fondaparinux. Few direct comparisons between...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.clinthera.2007.11.015

    authors: Kanaan AO,Silva MA,Donovan JL,Roy T,Al-Homsi AS

    更新日期:2007-11-01 00:00:00

  • Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.

    abstract:BACKGROUND:Preclinical studies have reported that the relative bioavailability of dalcetrapib, a modulator of cholesteryl ester transfer protein (CETP) inhibitor activity, was ∼60% higher when administered in the fed state compared with the fasting state. OBJECTIVE:This article reports on 3 studies conducted to assess...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.clinthera.2011.05.046

    authors: Derks M,Kawamura H,Abt M,Meneses-Lorente G,Phelan M,Ishikawa T

    更新日期:2011-06-01 00:00:00

  • Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

    abstract:BACKGROUND:Hypersensitivity reactions consist of a variable group of clinical findings and have been described for a wide variety of chemical compounds. OBJECTIVE:This review characterizes the clinical profile of hypersensitivity to the nucleoside reverse transcriptase inhibitor abacavir sulfate. METHODS:We performed...

    journal_title:Clinical therapeutics

    pub_type: 杂志文章

    doi:10.1016/s0149-2918(01)80132-6

    authors: Hetherington S,McGuirk S,Powell G,Cutrell A,Naderer O,Spreen B,Lafon S,Pearce G,Steel H

    更新日期:2001-10-01 00:00:00

  • Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology.

    abstract::A comparison of single-agent antimicrobial therapy in the treatment of patients with perforated or gangrenous appendicitis and peritonitis was performed in a double-blind, randomized, prospective trial. Pathologic documentation of advanced appendicitis and positive intraoperative specimen cultures were required for in...

    journal_title:Clinical therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Bennion RS,Thompson JE,Baron EJ,Finegold SM

    更新日期:1990-01-01 00:00:00